skip to primary navigationskip to content

Cambridge Centre for Neuropsychiatric Research

Department A-Z

 

"CCNR starts and ends with patients"


The Cambridge Centre for Neuropsychiatric Research

The Bahn laboratory is conducting an extensive research program to define the molecular basis of major neuropsychiatric disorders. Our focus is on schizophrenia, bipolar affective disorder, major depressive disorder and autistic and anxiety spectrum disorders. The internationally recognized scientific team is supported by state of the art laboratory facilities at the Department of Chemical Engineering and Biotechnology, Cambridge. The Cambridge Centre for Neuropsychiatric Research (CCNR), under the direction of Prof Sabine Bahn conducts and coordinates fundamental and applied research into the causes and treatment of major neuropsychiatric disorders, focusing on biomarkers and novel target discovery with the mission to translate research findings from the bench to the patient bedside. Following its foundation in 2004 the Bahn lab has received the second largest centre grant awarded by the Stanley Medical Research Institute (SMRI) and has continually attracted support and interest from prominent pharmaceutical companies and clinical partners around the world.

 

RSS Feed Latest news

CCNR at TACTICS meeting

Feb 03, 2014

Translational Adolescent and Childhood Therapeutic Interventions in Compulsive Syndromes

"Omics and Neurodegenerative Disorders" talk by Prof Bahn

Jan 07, 2014

Prof. Bahn will give a talk in the "Omics and Neurodegenerative Disorders" session at the upcoming Keystone Symposia, February 18th - 23rd, 2014, Taos (NM), USA

Call to create stronger mechanisms and structures for translational medicine

Jan 07, 2014

The Yearbook of the Academic Enterprise Awards (ACES) recognises the recommendations from the Bastion Round Table workshop at the European Parliament.

Bastion Round Table - From Lab to Clinic

Jun 04, 2013

During a round table discussion at the European Parliament Prof. Bahn and some other of Europe's leading experts provided insights from their experiences on the front lines of translational reasearch.

View all news